F.D.A. Approves an Immunotherapy Drug for Bladder Cancer by ANDREW POLLACK

By ANDREW POLLACK

The drug, Tecentriq from Roche, works by using the body’s immune system against tumors, and is the first drug of its type approved for bladder cancer.

Published: May 19, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1ssTm7M

from WordPress http://ift.tt/250Dvvq
via Hadi Aboukhater